PubRank

A Gregory Sorensen

Author PubWeight™ 193.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010 14.79
2 AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007 12.52
3 Angiogenesis in brain tumours. Nat Rev Neurosci 2007 6.82
4 Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. Cereb Cortex 2004 4.50
5 Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol 2009 4.17
6 Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009 3.85
7 Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol 2013 3.81
8 Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003 3.44
9 Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. J Clin Oncol 2010 3.43
10 DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011 3.18
11 An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 2005 3.09
12 Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J Clin Oncol 2009 3.02
13 Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axonal injury. AJNR Am J Neuroradiol 2004 2.78
14 A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke 2007 2.63
15 On-line automatic slice positioning for brain MR imaging. Neuroimage 2005 2.62
16 A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005 2.58
17 Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke 2008 2.34
18 Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype. J Nucl Med 2010 2.15
19 Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 2012 2.12
20 Correction for artifacts induced by B(0) and B(1) field inhomogeneities in pH-sensitive chemical exchange saturation transfer (CEST) imaging. Magn Reson Med 2007 2.09
21 Guidelines and recommendations for perfusion imaging in cerebral ischemia: A scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003 2.06
22 Investigation of optimizing and translating pH-sensitive pulsed-chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner. Magn Reson Med 2008 2.01
23 Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2008 1.88
24 CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002 1.85
25 Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 2005 1.76
26 Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res 2011 1.69
27 Imaging pH using the chemical exchange saturation transfer (CEST) MRI: Correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH. Magn Reson Med 2008 1.65
28 Comparison of manual and automatic section positioning of brain MR images. Radiology 2006 1.63
29 Preoperative and intraoperative diffusion tensor imaging-based fiber tracking in glioma surgery. Neurosurgery 2005 1.63
30 MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner. J Nucl Med 2011 1.63
31 Middle cerebral artery infarcts encompassing the insula are more prone to growth. Stroke 2008 1.58
32 Biomarkers in imaging: realizing radiology's future. Radiology 2003 1.54
33 Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002 1.53
34 Toward imaging biomarkers for osteoarthritis. Clin Orthop Relat Res 2004 1.51
35 Using the wild bootstrap to quantify uncertainty in diffusion tensor imaging. Hum Brain Mapp 2008 1.51
36 Admission international normalized ratio and acute infarct volume in ischemic stroke. Ann Neurol 2008 1.50
37 Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology 2011 1.48
38 Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat Med 2013 1.46
39 Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn Reson Med 2008 1.39
40 Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005 1.39
41 VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol 2009 1.37
42 The real estate factor: quantifying the impact of infarct location on stroke severity. Stroke 2006 1.34
43 Robust inference of baseline optical properties of the human head with three-dimensional segmentation from magnetic resonance imaging. Appl Opt 2003 1.32
44 Imaging and cancer: research strategy of the American College of Radiology Imaging Network. Radiology 2005 1.32
45 Predicting cerebral ischemic infarct volume with diffusion and perfusion MR imaging. AJNR Am J Neuroradiol 2002 1.28
46 Improved sensitivity to cerebral hemodynamics during brain activation with a time-gated optical system: analytical model and experimental validation. J Biomed Opt 2005 1.27
47 Early experience of translating pH-weighted MRI to image human subjects at 3 Tesla. Stroke 2010 1.25
48 Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest 2013 1.24
49 Molecular MRI of intracranial thrombus in a rat ischemic stroke model. Stroke 2010 1.24
50 Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009 1.23
51 Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 2002 1.23
52 Comatose patients with cardiac arrest: predicting clinical outcome with diffusion-weighted MR imaging. Radiology 2009 1.22
53 Magnetic resonance spectroscopy study of oxygen therapy in ischemic stroke. Stroke 2007 1.22
54 Intraoperative visualization of the pyramidal tract by diffusion-tensor-imaging-based fiber tracking. Neuroimage 2005 1.20
55 Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003 1.18
56 Fast multislice pH-weighted chemical exchange saturation transfer (CEST) MRI with Unevenly segmented RF irradiation. Magn Reson Med 2010 1.18
57 Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin Cancer Res 2010 1.17
58 Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curr Opin Neurol 2008 1.16
59 T1- and T2*-dominant extravasation correction in DSC-MRI: part I--theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011 1.16
60 Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model. Radiology 2010 1.15
61 Interexaminer difference in infarct volume measurements on MRI: a source of variance in stroke research. Stroke 2008 1.14
62 Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma. Cancer Res 2011 1.13
63 Diffusion imaging with prospective motion correction and reacquisition. Magn Reson Med 2011 1.13
64 Transient ischemic attack with infarction: a unique syndrome? Ann Neurol 2005 1.11
65 Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners. J Magn Reson 2010 1.11
66 Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol 2009 1.10
67 Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003 1.10
68 Intraoperative diffusion-tensor MR imaging: shifting of white matter tracts during neurosurgical procedures--initial experience. Radiology 2004 1.09
69 Simulation and optimization of pulsed radio frequency irradiation scheme for chemical exchange saturation transfer (CEST) MRI-demonstration of pH-weighted pulsed-amide proton CEST MRI in an animal model of acute cerebral ischemia. Magn Reson Med 2011 1.08
70 Mapping the spinal and supraspinal pathways of dynamic mechanical allodynia in the human trigeminal system using cardiac-gated fMRI. Neuroimage 2007 1.06
71 Abnormal cortical folding patterns within Broca's area in schizophrenia: evidence from structural MRI. Schizophr Res 2007 1.06
72 Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition. Radiology 2011 1.06
73 Diffusion-weighted MR imaging in closed head injury: high correlation with initial glasgow coma scale score and score on modified Rankin scale at discharge. Radiology 2004 1.05
74 Diffusion-weighted imaging for the evaluation of diffuse axonal injury in closed head injury. J Comput Assist Tomogr 2003 1.05
75 Evolution of water diffusion and anisotropy in hyperacute stroke: significant correlation between fractional anisotropy and T2. AJNR Am J Neuroradiol 2004 1.05
76 Applying instance-based techniques to prediction of final outcome in acute stroke. Artif Intell Med 2005 1.03
77 A new early and automated MRI-based predictor of motor improvement after stroke. Neurology 2012 1.01
78 Preoperative and intraoperative diffusion tensor imaging-based fiber tracking in glioma surgery. Neurosurgery 2007 1.01
79 Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study. Neuro Oncol 2013 1.00
80 Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: an unlikely role for cerebral blood flow. Brain Res 2011 0.95
81 The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol 2002 0.94
82 Stability of large diffusion/perfusion mismatch in anterior circulation strokes for 4 or more hours. BMC Neurol 2010 0.94
83 Low-power adiabatic sequences for in vivo localized two-dimensional chemical shift correlated MR spectroscopy. Magn Reson Med 2010 0.93
84 Automated perfusion-weighted MRI using localized arterial input functions. J Magn Reson Imaging 2006 0.93
85 Age-dependent susceptibility to infarct growth in women. Stroke 2011 0.92
86 Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model. PLoS One 2011 0.92
87 Characterization and evolution of diffusion MR imaging abnormalities in stroke patients undergoing intra-arterial thrombolysis. AJNR Am J Neuroradiol 2004 0.92
88 Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. Radiology 2011 0.92
89 The medical device excise tax--before it begins? N Engl J Med 2013 0.92
90 Perfusion MR imaging: moving forward. Radiology 2008 0.92
91 Technical aspects of perfusion-weighted imaging. Neuroimaging Clin N Am 2005 0.91
92 Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol 2003 0.91
93 Imaging stroke patients with unclear onset times. Neuroimaging Clin N Am 2011 0.90
94 Using imaging biomarkers to accelerate drug development and clinical trials. Drug Discov Today 2005 0.89
95 In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model. Neuro Oncol 2010 0.89
96 Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol. Radiology 2003 0.88
97 Effect of using local arterial input functions on cerebral blood flow estimation. J Magn Reson Imaging 2006 0.88
98 Strategies for improving the detection of fMRI activation in trigeminal pathways with cardiac gating. Neuroimage 2006 0.87
99 Diffusion and diffusion tensor imaging in brain cancer. Semin Radiat Oncol 2011 0.87
100 Fast radio-frequency enforced steady state (FRESS) spin echo MRI for quantitative T2 mapping: minimizing the apparent repetition time (TR) dependence for fast T2 measurement. NMR Biomed 2011 0.87
101 Real-time motion and B0 correction for localized adiabatic selective refocusing (LASER) MRSI using echo planar imaging volumetric navigators. NMR Biomed 2011 0.86
102 Correlation chemical shift imaging with low-power adiabatic pulses and constant-density spiral trajectories. NMR Biomed 2011 0.85
103 T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011 0.85
104 Physiological noise in MR images: an indicator of the tissue response to ischemia? J Magn Reson Imaging 2008 0.85
105 Incidental findings in brain MRI research: what do we owe our subjects? J Am Coll Radiol 2011 0.84
106 Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. Neuro Oncol 2013 0.83
107 Real-time RF pulse adjustment for B0 drift correction. Magn Reson Med 2006 0.82
108 Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation. Oncologist 2013 0.81
109 Iron-induced susceptibility effect at the globus pallidus causes underestimation of flow and volume on dynamic susceptibility contrast-enhanced MR perfusion images. AJNR Am J Neuroradiol 2002 0.80
110 Case records of the Massachusetts General Hospital. Case 17-2012. A 54-year-old man with visual-field loss and a mass in the brain. N Engl J Med 2012 0.80
111 Diffusion tensor imaging shows structural remodeling of stroke mirror region: results from a pilot study. Eur Neurol 2012 0.80
112 Apparently, diffusion coefficient value and stroke treatment remains mysterious. AJNR Am J Neuroradiol 2002 0.79
113 Lower hemoglobin correlates with larger stroke volumes in acute ischemic stroke. Cerebrovasc Dis Extra 2011 0.79
114 Anti-vascular endothelial growth factor therapy for malignant glioma. Curr Neurol Neurosci Rep 2009 0.79
115 Diffusion tensor magnetic resonance imaging of brain tumors. Neurosurg Clin N Am 2005 0.79
116 Prediction of early stroke risk in transient symptoms with infarction: relevance to the new tissue-based definition. Stroke 2011 0.77
117 Advances in imaging. Stroke 2009 0.77
118 Diffusion tensor magnetic resonance imaging of brain tumors. Magn Reson Imaging Clin N Am 2006 0.77
119 Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy. J Thorac Oncol 2008 0.76
120 Advances in imaging 2006. Stroke 2007 0.76
121 Imaging biomarkers predictive of disease/therapy outcome: ischemic stroke and drug development. Prog Drug Res 2005 0.75
122 MRI measurements of water diffusion: impact of region of interest selection on ischemic quantification. Eur J Radiol 2004 0.75
123 Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial. J Magn Reson Imaging 2013 0.75
124 Perfusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol 2002 0.75
125 Diffusion magnetic resonance imaging of acute ischemic stroke. Semin Roentgenol 2002 0.75